nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—CYP3A7—Ifosfamide—germ cell cancer	0.142	0.17	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.142	0.17	CbGbCtD
Norethindrone—CYP3A5—Ifosfamide—germ cell cancer	0.107	0.127	CbGbCtD
Norethindrone—CYP2C19—Ifosfamide—germ cell cancer	0.086	0.103	CbGbCtD
Norethindrone—ABCB1—Dactinomycin—germ cell cancer	0.0588	0.0702	CbGbCtD
Norethindrone—CYP3A5—Etoposide—germ cell cancer	0.051	0.0608	CbGbCtD
Norethindrone—ALB—Methotrexate—germ cell cancer	0.0419	0.05	CbGbCtD
Norethindrone—CYP3A4—Ifosfamide—germ cell cancer	0.0416	0.0496	CbGbCtD
Norethindrone—ABCB1—Vinblastine—germ cell cancer	0.0368	0.0439	CbGbCtD
Norethindrone—ABCB1—Cisplatin—germ cell cancer	0.0338	0.0403	CbGbCtD
Norethindrone—ABCB1—Etoposide—germ cell cancer	0.0332	0.0396	CbGbCtD
Norethindrone—CYP3A4—Vinblastine—germ cell cancer	0.0221	0.0263	CbGbCtD
Norethindrone—ABCB1—Methotrexate—germ cell cancer	0.0219	0.0262	CbGbCtD
Norethindrone—CYP3A4—Etoposide—germ cell cancer	0.0199	0.0237	CbGbCtD
Norethindrone—SHBG—seminiferous tubule of testis—germ cell cancer	0.0105	0.242	CbGeAlD
Norethindrone—Infertility—Ifosfamide—germ cell cancer	0.00555	0.0473	CcSEcCtD
Norethindrone—Cerebral thrombosis—Methotrexate—germ cell cancer	0.00547	0.0466	CcSEcCtD
Norethindrone—CYP2C19—urine—germ cell cancer	0.0027	0.062	CbGeAlD
Norethindrone—Infertility—Methotrexate—germ cell cancer	0.00263	0.0224	CcSEcCtD
Norethindrone—Thromboembolic event—Methotrexate—germ cell cancer	0.00254	0.0217	CcSEcCtD
Norethindrone—Deep vein thrombosis—Ifosfamide—germ cell cancer	0.00238	0.0203	CcSEcCtD
Norethindrone—Blindness—Cisplatin—germ cell cancer	0.00226	0.0192	CcSEcCtD
Norethindrone—Optic neuritis—Cisplatin—germ cell cancer	0.00203	0.0173	CcSEcCtD
Norethindrone—PGR—blood vessel—germ cell cancer	0.00198	0.0455	CbGeAlD
Norethindrone—Tenderness—Bleomycin—germ cell cancer	0.00194	0.0166	CcSEcCtD
Norethindrone—Optic neuritis—Etoposide—germ cell cancer	0.00186	0.0159	CcSEcCtD
Norethindrone—Neoplasm malignant—Ifosfamide—germ cell cancer	0.0017	0.0145	CcSEcCtD
Norethindrone—Tenderness—Ifosfamide—germ cell cancer	0.00166	0.0142	CcSEcCtD
Norethindrone—Amenorrhoea—Ifosfamide—germ cell cancer	0.00165	0.0141	CcSEcCtD
Norethindrone—CYP3A4—urine—germ cell cancer	0.0016	0.0367	CbGeAlD
Norethindrone—SHBG—neck—germ cell cancer	0.00157	0.0362	CbGeAlD
Norethindrone—Pulmonary embolism—Ifosfamide—germ cell cancer	0.00145	0.0123	CcSEcCtD
Norethindrone—Tenderness—Cisplatin—germ cell cancer	0.00143	0.0122	CcSEcCtD
Norethindrone—Thrombophlebitis—Ifosfamide—germ cell cancer	0.00121	0.0104	CcSEcCtD
Norethindrone—SHBG—brainstem—germ cell cancer	0.0012	0.0276	CbGeAlD
Norethindrone—Deep vein thrombosis—Methotrexate—germ cell cancer	0.00113	0.0096	CcSEcCtD
Norethindrone—Depression—Vinblastine—germ cell cancer	0.00112	0.00954	CcSEcCtD
Norethindrone—Acute coronary syndrome—Vinblastine—germ cell cancer	0.00111	0.00943	CcSEcCtD
Norethindrone—Renal impairment—Ifosfamide—germ cell cancer	0.0011	0.00942	CcSEcCtD
Norethindrone—Myocardial infarction—Vinblastine—germ cell cancer	0.0011	0.00938	CcSEcCtD
Norethindrone—Embolism—Methotrexate—germ cell cancer	0.00107	0.0091	CcSEcCtD
Norethindrone—Pain in extremity—Ifosfamide—germ cell cancer	0.00105	0.00896	CcSEcCtD
Norethindrone—Haemoglobin—Vinblastine—germ cell cancer	0.00101	0.00863	CcSEcCtD
Norethindrone—Haemorrhage—Vinblastine—germ cell cancer	0.00101	0.00859	CcSEcCtD
Norethindrone—CYP3A7—endocrine gland—germ cell cancer	0.001	0.023	CbGeAlD
Norethindrone—Breast disorder—Ifosfamide—germ cell cancer	0.00095	0.0081	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Cisplatin—germ cell cancer	0.000937	0.00798	CcSEcCtD
Norethindrone—Acute coronary syndrome—Bleomycin—germ cell cancer	0.000935	0.00797	CcSEcCtD
Norethindrone—Myocardial infarction—Bleomycin—germ cell cancer	0.000929	0.00792	CcSEcCtD
Norethindrone—PGR—decidua—germ cell cancer	0.000911	0.0209	CbGeAlD
Norethindrone—SHBG—gonad—germ cell cancer	0.000891	0.0205	CbGeAlD
Norethindrone—Alopecia—Vinblastine—germ cell cancer	0.000891	0.00759	CcSEcCtD
Norethindrone—SHBG—uterus—germ cell cancer	0.000885	0.0203	CbGeAlD
Norethindrone—SHBG—pituitary gland—germ cell cancer	0.000869	0.02	CbGeAlD
Norethindrone—Anaphylactoid reaction—Etoposide—germ cell cancer	0.000858	0.00731	CcSEcCtD
Norethindrone—Haemoglobin—Bleomycin—germ cell cancer	0.000856	0.00729	CcSEcCtD
Norethindrone—Haemorrhage—Bleomycin—germ cell cancer	0.000851	0.00725	CcSEcCtD
Norethindrone—Breast disorder—Cisplatin—germ cell cancer	0.000819	0.00698	CcSEcCtD
Norethindrone—Acute coronary syndrome—Ifosfamide—germ cell cancer	0.000799	0.00681	CcSEcCtD
Norethindrone—PGR—uterus—germ cell cancer	0.000797	0.0183	CbGeAlD
Norethindrone—Renal failure—Ifosfamide—germ cell cancer	0.000797	0.00679	CcSEcCtD
Norethindrone—Myocardial infarction—Ifosfamide—germ cell cancer	0.000794	0.00677	CcSEcCtD
Norethindrone—Hepatitis—Dactinomycin—germ cell cancer	0.000794	0.00677	CcSEcCtD
Norethindrone—PGR—pituitary gland—germ cell cancer	0.000783	0.018	CbGeAlD
Norethindrone—SHBG—adrenal gland—germ cell cancer	0.000776	0.0178	CbGeAlD
Norethindrone—Hepatobiliary disease—Ifosfamide—germ cell cancer	0.000766	0.00653	CcSEcCtD
Norethindrone—Convulsion—Vinblastine—germ cell cancer	0.00076	0.00648	CcSEcCtD
Norethindrone—Alopecia—Bleomycin—germ cell cancer	0.000752	0.00641	CcSEcCtD
Norethindrone—SHBG—bone marrow—germ cell cancer	0.000751	0.0173	CbGeAlD
Norethindrone—Erythema multiforme—Dactinomycin—germ cell cancer	0.000751	0.0064	CcSEcCtD
Norethindrone—Haemoglobin—Ifosfamide—germ cell cancer	0.000731	0.00623	CcSEcCtD
Norethindrone—Haemorrhage—Ifosfamide—germ cell cancer	0.000727	0.0062	CcSEcCtD
Norethindrone—Hepatitis—Ifosfamide—germ cell cancer	0.000727	0.0062	CcSEcCtD
Norethindrone—SHBG—female gonad—germ cell cancer	0.000724	0.0166	CbGeAlD
Norethindrone—Connective tissue disorder—Ifosfamide—germ cell cancer	0.000715	0.00609	CcSEcCtD
Norethindrone—Alopecia—Dactinomycin—germ cell cancer	0.000702	0.00598	CcSEcCtD
Norethindrone—PGR—adrenal gland—germ cell cancer	0.000699	0.0161	CbGeAlD
Norethindrone—Progesterone—SLC22A3—germ cell cancer	0.000689	0.514	CrCbGaD
Norethindrone—Acute coronary syndrome—Cisplatin—germ cell cancer	0.000689	0.00587	CcSEcCtD
Norethindrone—Erythema multiforme—Ifosfamide—germ cell cancer	0.000688	0.00586	CcSEcCtD
Norethindrone—Renal failure—Cisplatin—germ cell cancer	0.000687	0.00585	CcSEcCtD
Norethindrone—Pulmonary embolism—Methotrexate—germ cell cancer	0.000685	0.00584	CcSEcCtD
Norethindrone—Myocardial infarction—Cisplatin—germ cell cancer	0.000685	0.00584	CcSEcCtD
Norethindrone—SHBG—endocrine gland—germ cell cancer	0.000673	0.0155	CbGeAlD
Norethindrone—Hepatobiliary disease—Cisplatin—germ cell cancer	0.000661	0.00563	CcSEcCtD
Norethindrone—Immune system disorder—Ifosfamide—germ cell cancer	0.000657	0.0056	CcSEcCtD
Norethindrone—PGR—female gonad—germ cell cancer	0.000652	0.015	CbGeAlD
Norethindrone—Testosterone—SLC22A3—germ cell cancer	0.000651	0.486	CrCbGaD
Norethindrone—Alopecia—Ifosfamide—germ cell cancer	0.000643	0.00548	CcSEcCtD
Norethindrone—SHBG—testis—germ cell cancer	0.000642	0.0147	CbGeAlD
Norethindrone—ALB—adrenal gland—germ cell cancer	0.000641	0.0147	CbGeAlD
Norethindrone—Mental disorder—Ifosfamide—germ cell cancer	0.000637	0.00543	CcSEcCtD
Norethindrone—Acute coronary syndrome—Etoposide—germ cell cancer	0.000631	0.00538	CcSEcCtD
Norethindrone—Renal failure—Etoposide—germ cell cancer	0.000629	0.00536	CcSEcCtD
Norethindrone—Myocardial infarction—Etoposide—germ cell cancer	0.000627	0.00535	CcSEcCtD
Norethindrone—Connective tissue disorder—Cisplatin—germ cell cancer	0.000616	0.00525	CcSEcCtD
Norethindrone—ABCB1—blood vessel—germ cell cancer	0.000612	0.0141	CbGeAlD
Norethindrone—PGR—endocrine gland—germ cell cancer	0.000606	0.0139	CbGeAlD
Norethindrone—Hepatobiliary disease—Etoposide—germ cell cancer	0.000605	0.00516	CcSEcCtD
Norethindrone—Oedema—Bleomycin—germ cell cancer	0.000605	0.00515	CcSEcCtD
Norethindrone—Anaphylactic shock—Bleomycin—germ cell cancer	0.000605	0.00515	CcSEcCtD
Norethindrone—PGR—head—germ cell cancer	0.000599	0.0138	CbGeAlD
Norethindrone—SHBG—cerebellum—germ cell cancer	0.000593	0.0136	CbGeAlD
Norethindrone—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000586	0.00499	CcSEcCtD
Norethindrone—PGR—testis—germ cell cancer	0.000578	0.0133	CbGeAlD
Norethindrone—Thrombophlebitis—Methotrexate—germ cell cancer	0.000575	0.0049	CcSEcCtD
Norethindrone—Photosensitivity—Methotrexate—germ cell cancer	0.000567	0.00483	CcSEcCtD
Norethindrone—Immune system disorder—Cisplatin—germ cell cancer	0.000566	0.00483	CcSEcCtD
Norethindrone—Abdominal pain—Vinblastine—germ cell cancer	0.000566	0.00482	CcSEcCtD
Norethindrone—Oedema—Dactinomycin—germ cell cancer	0.000564	0.00481	CcSEcCtD
Norethindrone—Alopecia—Cisplatin—germ cell cancer	0.000554	0.00472	CcSEcCtD
Norethindrone—Convulsion—Ifosfamide—germ cell cancer	0.000549	0.00468	CcSEcCtD
Norethindrone—Erythema multiforme—Etoposide—germ cell cancer	0.000543	0.00463	CcSEcCtD
Norethindrone—Flatulence—Cisplatin—germ cell cancer	0.000538	0.00458	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000535	0.00456	CcSEcCtD
Norethindrone—PGR—cerebellum—germ cell cancer	0.000534	0.0123	CbGeAlD
Norethindrone—ALB—testis—germ cell cancer	0.00053	0.0122	CbGeAlD
Norethindrone—Hypersensitivity—Vinblastine—germ cell cancer	0.000528	0.0045	CcSEcCtD
Norethindrone—Immune system disorder—Etoposide—germ cell cancer	0.000519	0.00442	CcSEcCtD
Norethindrone—Oedema—Ifosfamide—germ cell cancer	0.000517	0.0044	CcSEcCtD
Norethindrone—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000517	0.0044	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000514	0.00438	CcSEcCtD
Norethindrone—Asthenia—Vinblastine—germ cell cancer	0.000514	0.00438	CcSEcCtD
Norethindrone—Alopecia—Etoposide—germ cell cancer	0.000508	0.00433	CcSEcCtD
Norethindrone—Skin disorder—Ifosfamide—germ cell cancer	0.000502	0.00428	CcSEcCtD
Norethindrone—Fatigue—Dactinomycin—germ cell cancer	0.000486	0.00414	CcSEcCtD
Norethindrone—SHBG—brain—germ cell cancer	0.000482	0.0111	CbGeAlD
Norethindrone—Urticaria—Bleomycin—germ cell cancer	0.00048	0.00409	CcSEcCtD
Norethindrone—Dizziness—Vinblastine—germ cell cancer	0.000474	0.00404	CcSEcCtD
Norethindrone—Convulsion—Cisplatin—germ cell cancer	0.000473	0.00403	CcSEcCtD
Norethindrone—Mood swings—Methotrexate—germ cell cancer	0.000471	0.00402	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000462	0.00393	CcSEcCtD
Norethindrone—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000461	0.00393	CcSEcCtD
Norethindrone—Somnolence—Ifosfamide—germ cell cancer	0.000459	0.00392	CcSEcCtD
Norethindrone—Vomiting—Vinblastine—germ cell cancer	0.000455	0.00388	CcSEcCtD
Norethindrone—Breast disorder—Methotrexate—germ cell cancer	0.00045	0.00383	CcSEcCtD
Norethindrone—Headache—Vinblastine—germ cell cancer	0.000449	0.00382	CcSEcCtD
Norethindrone—CYP2C19—endocrine gland—germ cell cancer	0.000448	0.0103	CbGeAlD
Norethindrone—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000446	0.0038	CcSEcCtD
Norethindrone—Abdominal pain—Dactinomycin—germ cell cancer	0.000446	0.0038	CcSEcCtD
Norethindrone—Fatigue—Ifosfamide—germ cell cancer	0.000446	0.0038	CcSEcCtD
Norethindrone—Oedema—Cisplatin—germ cell cancer	0.000446	0.0038	CcSEcCtD
Norethindrone—Anaphylactic shock—Cisplatin—germ cell cancer	0.000446	0.0038	CcSEcCtD
Norethindrone—Hypersensitivity—Bleomycin—germ cell cancer	0.000446	0.0038	CcSEcCtD
Norethindrone—Asthenia—Bleomycin—germ cell cancer	0.000434	0.0037	CcSEcCtD
Norethindrone—PGR—brain—germ cell cancer	0.000434	0.00997	CbGeAlD
Norethindrone—Convulsion—Etoposide—germ cell cancer	0.000433	0.00369	CcSEcCtD
Norethindrone—Skin disorder—Cisplatin—germ cell cancer	0.000433	0.00369	CcSEcCtD
Norethindrone—Pruritus—Bleomycin—germ cell cancer	0.000428	0.00365	CcSEcCtD
Norethindrone—Nausea—Vinblastine—germ cell cancer	0.000425	0.00362	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000423	0.0036	CcSEcCtD
Norethindrone—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000423	0.0036	CcSEcCtD
Norethindrone—PGR—lymph node—germ cell cancer	0.000419	0.00963	CbGeAlD
Norethindrone—Hypersensitivity—Dactinomycin—germ cell cancer	0.000416	0.00354	CcSEcCtD
Norethindrone—Urticaria—Ifosfamide—germ cell cancer	0.000411	0.0035	CcSEcCtD
Norethindrone—Abdominal pain—Ifosfamide—germ cell cancer	0.000409	0.00348	CcSEcCtD
Norethindrone—Anaphylactic shock—Etoposide—germ cell cancer	0.000408	0.00348	CcSEcCtD
Norethindrone—Asthenia—Dactinomycin—germ cell cancer	0.000405	0.00345	CcSEcCtD
Norethindrone—ALB—brain—germ cell cancer	0.000398	0.00914	CbGeAlD
Norethindrone—Skin disorder—Etoposide—germ cell cancer	0.000397	0.00338	CcSEcCtD
Norethindrone—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000392	0.00334	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000385	0.00328	CcSEcCtD
Norethindrone—Vomiting—Bleomycin—germ cell cancer	0.000385	0.00328	CcSEcCtD
Norethindrone—ALB—lymph node—germ cell cancer	0.000384	0.00883	CbGeAlD
Norethindrone—Drowsiness—Methotrexate—germ cell cancer	0.000383	0.00327	CcSEcCtD
Norethindrone—Depression—Methotrexate—germ cell cancer	0.000382	0.00326	CcSEcCtD
Norethindrone—Rash—Bleomycin—germ cell cancer	0.000381	0.00325	CcSEcCtD
Norethindrone—Dermatitis—Bleomycin—germ cell cancer	0.000381	0.00325	CcSEcCtD
Norethindrone—Hypersensitivity—Ifosfamide—germ cell cancer	0.000381	0.00325	CcSEcCtD
Norethindrone—CYP3A5—female gonad—germ cell cancer	0.000379	0.00871	CbGeAlD
Norethindrone—ABCB1—trigeminal ganglion—germ cell cancer	0.000378	0.00869	CbGeAlD
Norethindrone—Renal failure—Methotrexate—germ cell cancer	0.000377	0.00321	CcSEcCtD
Norethindrone—Asthenia—Ifosfamide—germ cell cancer	0.000371	0.00316	CcSEcCtD
Norethindrone—Pruritus—Ifosfamide—germ cell cancer	0.000366	0.00312	CcSEcCtD
Norethindrone—ABCB1—embryo—germ cell cancer	0.000365	0.00839	CbGeAlD
Norethindrone—Somnolence—Etoposide—germ cell cancer	0.000363	0.00309	CcSEcCtD
Norethindrone—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000363	0.00309	CcSEcCtD
Norethindrone—Nausea—Bleomycin—germ cell cancer	0.000359	0.00306	CcSEcCtD
Norethindrone—Vomiting—Dactinomycin—germ cell cancer	0.000359	0.00306	CcSEcCtD
Norethindrone—Rash—Dactinomycin—germ cell cancer	0.000356	0.00303	CcSEcCtD
Norethindrone—CYP3A5—endocrine gland—germ cell cancer	0.000353	0.0081	CbGeAlD
Norethindrone—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000352	0.003	CcSEcCtD
Norethindrone—Fatigue—Etoposide—germ cell cancer	0.000352	0.003	CcSEcCtD
Norethindrone—Haemoglobin—Methotrexate—germ cell cancer	0.000346	0.00295	CcSEcCtD
Norethindrone—Haemorrhage—Methotrexate—germ cell cancer	0.000344	0.00293	CcSEcCtD
Norethindrone—Hepatitis—Methotrexate—germ cell cancer	0.000344	0.00293	CcSEcCtD
Norethindrone—Dizziness—Ifosfamide—germ cell cancer	0.000342	0.00291	CcSEcCtD
Norethindrone—Nausea—Dactinomycin—germ cell cancer	0.000335	0.00286	CcSEcCtD
Norethindrone—Gastrointestinal pain—Etoposide—germ cell cancer	0.000334	0.00284	CcSEcCtD
Norethindrone—Vomiting—Ifosfamide—germ cell cancer	0.000329	0.0028	CcSEcCtD
Norethindrone—Hypersensitivity—Cisplatin—germ cell cancer	0.000328	0.0028	CcSEcCtD
Norethindrone—Rash—Ifosfamide—germ cell cancer	0.000326	0.00278	CcSEcCtD
Norethindrone—Dermatitis—Ifosfamide—germ cell cancer	0.000326	0.00277	CcSEcCtD
Norethindrone—Erythema multiforme—Methotrexate—germ cell cancer	0.000325	0.00277	CcSEcCtD
Norethindrone—Urticaria—Etoposide—germ cell cancer	0.000324	0.00276	CcSEcCtD
Norethindrone—ABCB1—retina—germ cell cancer	0.000323	0.00742	CbGeAlD
Norethindrone—Abdominal pain—Etoposide—germ cell cancer	0.000323	0.00275	CcSEcCtD
Norethindrone—Asthenia—Cisplatin—germ cell cancer	0.00032	0.00272	CcSEcCtD
Norethindrone—Immune system disorder—Methotrexate—germ cell cancer	0.000311	0.00265	CcSEcCtD
Norethindrone—Nausea—Ifosfamide—germ cell cancer	0.000307	0.00262	CcSEcCtD
Norethindrone—Alopecia—Methotrexate—germ cell cancer	0.000304	0.00259	CcSEcCtD
Norethindrone—Mental disorder—Methotrexate—germ cell cancer	0.000302	0.00257	CcSEcCtD
Norethindrone—Hypersensitivity—Etoposide—germ cell cancer	0.000301	0.00256	CcSEcCtD
Norethindrone—ABCB1—telencephalon—germ cell cancer	0.000297	0.00682	CbGeAlD
Norethindrone—Asthenia—Etoposide—germ cell cancer	0.000293	0.0025	CcSEcCtD
Norethindrone—Pruritus—Etoposide—germ cell cancer	0.000289	0.00246	CcSEcCtD
Norethindrone—Vomiting—Cisplatin—germ cell cancer	0.000283	0.00241	CcSEcCtD
Norethindrone—ABCB1—decidua—germ cell cancer	0.000282	0.00647	CbGeAlD
Norethindrone—Rash—Cisplatin—germ cell cancer	0.000281	0.00239	CcSEcCtD
Norethindrone—Dermatitis—Cisplatin—germ cell cancer	0.000281	0.00239	CcSEcCtD
Norethindrone—Dizziness—Etoposide—germ cell cancer	0.00027	0.0023	CcSEcCtD
Norethindrone—Nausea—Cisplatin—germ cell cancer	0.000265	0.00226	CcSEcCtD
Norethindrone—CYP3A4—endocrine gland—germ cell cancer	0.000265	0.00608	CbGeAlD
Norethindrone—Convulsion—Methotrexate—germ cell cancer	0.00026	0.00221	CcSEcCtD
Norethindrone—Vomiting—Etoposide—germ cell cancer	0.00026	0.00221	CcSEcCtD
Norethindrone—Rash—Etoposide—germ cell cancer	0.000257	0.00219	CcSEcCtD
Norethindrone—Dermatitis—Etoposide—germ cell cancer	0.000257	0.00219	CcSEcCtD
Norethindrone—Headache—Etoposide—germ cell cancer	0.000256	0.00218	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000253	0.00216	CcSEcCtD
Norethindrone—ABCB1—gonad—germ cell cancer	0.000248	0.00569	CbGeAlD
Norethindrone—ABCB1—uterus—germ cell cancer	0.000246	0.00566	CbGeAlD
Norethindrone—Anaphylactic shock—Methotrexate—germ cell cancer	0.000245	0.00208	CcSEcCtD
Norethindrone—Nausea—Etoposide—germ cell cancer	0.000242	0.00207	CcSEcCtD
Norethindrone—ABCB1—pituitary gland—germ cell cancer	0.000242	0.00556	CbGeAlD
Norethindrone—Skin disorder—Methotrexate—germ cell cancer	0.000238	0.00202	CcSEcCtD
Norethindrone—ABCB1—medulla oblongata—germ cell cancer	0.000233	0.00536	CbGeAlD
Norethindrone—Insomnia—Methotrexate—germ cell cancer	0.000221	0.00188	CcSEcCtD
Norethindrone—Somnolence—Methotrexate—germ cell cancer	0.000217	0.00185	CcSEcCtD
Norethindrone—ABCB1—adrenal gland—germ cell cancer	0.000216	0.00496	CbGeAlD
Norethindrone—Dyspepsia—Methotrexate—germ cell cancer	0.000215	0.00183	CcSEcCtD
Norethindrone—ABCB1—midbrain—germ cell cancer	0.000213	0.0049	CbGeAlD
Norethindrone—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000211	0.0018	CcSEcCtD
Norethindrone—Fatigue—Methotrexate—germ cell cancer	0.000211	0.0018	CcSEcCtD
Norethindrone—ABCB1—bone marrow—germ cell cancer	0.000209	0.0048	CbGeAlD
Norethindrone—ABCB1—spinal cord—germ cell cancer	0.000208	0.00478	CbGeAlD
Norethindrone—ABCB1—female gonad—germ cell cancer	0.000201	0.00463	CbGeAlD
Norethindrone—Gastrointestinal pain—Methotrexate—germ cell cancer	0.0002	0.0017	CcSEcCtD
Norethindrone—Urticaria—Methotrexate—germ cell cancer	0.000194	0.00166	CcSEcCtD
Norethindrone—Abdominal pain—Methotrexate—germ cell cancer	0.000193	0.00165	CcSEcCtD
Norethindrone—ABCB1—endocrine gland—germ cell cancer	0.000187	0.0043	CbGeAlD
Norethindrone—ABCB1—head—germ cell cancer	0.000185	0.00425	CbGeAlD
Norethindrone—Hypersensitivity—Methotrexate—germ cell cancer	0.00018	0.00154	CcSEcCtD
Norethindrone—ABCB1—testis—germ cell cancer	0.000179	0.0041	CbGeAlD
Norethindrone—Asthenia—Methotrexate—germ cell cancer	0.000175	0.0015	CcSEcCtD
Norethindrone—Pruritus—Methotrexate—germ cell cancer	0.000173	0.00147	CcSEcCtD
Norethindrone—ABCB1—cerebellum—germ cell cancer	0.000165	0.00379	CbGeAlD
Norethindrone—Dizziness—Methotrexate—germ cell cancer	0.000162	0.00138	CcSEcCtD
Norethindrone—Vomiting—Methotrexate—germ cell cancer	0.000155	0.00132	CcSEcCtD
Norethindrone—Rash—Methotrexate—germ cell cancer	0.000154	0.00131	CcSEcCtD
Norethindrone—Dermatitis—Methotrexate—germ cell cancer	0.000154	0.00131	CcSEcCtD
Norethindrone—Headache—Methotrexate—germ cell cancer	0.000153	0.00131	CcSEcCtD
Norethindrone—Nausea—Methotrexate—germ cell cancer	0.000145	0.00124	CcSEcCtD
Norethindrone—ABCB1—brain—germ cell cancer	0.000134	0.00308	CbGeAlD
Norethindrone—ABCB1—lymph node—germ cell cancer	0.000129	0.00298	CbGeAlD
